Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases Notified -
Hong Kong and New Zealand among the 10 easiest jurisdictions to do business in, says the GBCI 2026 Notified -
DutyFreeFood.com Opens Global Vendor & Investor Enrollment Ahead of Fall 2026 Launch of the World’s First Global Online Duty-Free Food, Spirits & Beverage Marketplace Notified -
Persona AI Collaborates with Under Armour to Explore Performance Materials for Humanoid Robotics Notified -